2.5 mg retatrutide Dosage: Week-to-Week Schedule & Chart Retatrutide 12mg - Peptas
Description
What are the main side effects observed in Retatrutide research

In mice and rats, standard two-year carcinogenicity studies with insulin glargine were performed at doses up to 0.455 mg/kg, which was for the rat approximately 65 times the recommended human subcutaneous starting dosage of 0.2 units/kg/day (0.007 mg/kg/day) on a mg/kg basis

The rate of retropharyngeal abscesses more than doubled from 0.1 cases per 10,000 people in 2000 to 0.22 cases per 10,000 people in 2009

Healthy fatslike monounsaturated and omega-3 fatty acidshave been shown to boost GLP-1 levels, help regulate appetite, and support sustainable weight loss (Cole, 2025)
